You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-CoV-2 Vaccine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Huai'an (Inactivated SARS-CoV-2 Vaccine (Vero cell))

Completed
  • COVID-19
  • Inactivated SARS-CoV-2 Vaccine (Vero cell）
  • Huai'an, Jiangsu, China
    Jingliang Wu
Apr 12, 2022

SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy

Recruiting
  • Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
  • COVID-19 serology IgG
  • Detroit, Michigan
    Henry Ford Health System
Jul 19, 2022

COVID-19, Vaccines Trial in Santiago (CoronaVac®, Omicron Vaccine, Trivalent Vaccine)

Recruiting
  • COVID-19
  • Vaccines
  • CoronaVac®
  • +2 more
  • Santiago, Metropolitana, Chile
  • +2 more
Jan 12, 2023

COVID-19 (Healthy Volunteers) Trial in United States (SARS-CoV-2 vaccine formulation 1 with adjuvant 1, SARS-CoV-2 vaccine

Completed
  • COVID-19 (Healthy Volunteers)
  • SARS-CoV-2 vaccine formulation 1 with adjuvant 1
  • +5 more
  • Birmingham, Alabama
  • +10 more
Apr 22, 2022

COVID-19 Trial in Xi'an (Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2, Inactivated SARS-CoV-2 Vaccine

Active, not recruiting
  • COVID-19
  • Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2
  • +6 more
  • Xi'an, Shanxi, China
    Yaliang county Center for Disease Control and Prevention
Dec 13, 2021

Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)

Recruiting
  • Covid19
  • CVXGA1 low dose
  • CVXGA1 high dose
  • Bardstown, Kentucky
  • +3 more
Aug 16, 2022

COVID-19 Infection Trial in Duarte (Placebo Administration, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1)

Recruiting
  • COVID-19 Infection
  • Placebo Administration
  • Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Dec 15, 2021

COVID-19 Trial in Xinqi (High-dosage SARS-CoV-2 vaccine, Medium-dosage SARS-CoV-2 vaccine)

Active, not recruiting
  • COVID-19
  • High-dosage SARS-CoV-2 vaccine
  • Medium-dosage SARS-CoV-2 vaccine
  • Xinqi, Jiangsu, China
    Xinqi City Center for Disease Control and Prevention
Feb 13, 2022

COVID-19 Trial (SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated)

Not yet recruiting
  • COVID-19
  • SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated
  • (no location specified)
Dec 23, 2021

COVID-19, Rabies Trial in Guiyang, Taiyuan (coadministration, COVID-19 vaccine, rabies vaccine)

Recruiting
  • COVID-19
  • Rabies
  • coadministration
  • +2 more
  • Guiyang, China
  • +1 more
Jul 27, 2022

SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among

Completed
  • SARS-CoV2 Infection
  • +3 more
  • IM injection of vaccination (mRNA vaccination)
  • IM injection of vaccination (vector based vaccination)
  • Hildesheim, Niedersachsen, Germany
    Helios Hospital Hildesheim
Dec 29, 2022

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

Not yet recruiting
  • COVID-19 Vaccine
  • COVID-19
  • 50 μg Baiya SARS-CoV-2 Vax 2
  • Placebo
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
May 23, 2023

COVID-19 Trial in Chongqing, Jinan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, Placebo)

Active, not recruiting
  • COVID-19
  • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
  • Placebo
  • Chongqing, Chongqing, China
  • +1 more
Jan 11, 2023

COVID-19 Trial in Shijiazhuang (Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28, Two doses of

Active, not recruiting
  • COVID-19
  • Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28
  • +2 more
  • Shijiazhuang, Hebei, China
    Zanhuang county Center for Disease Control and Prevention
Apr 12, 2022

Understand is COVID-19 Vaccine BNT162b2 is Safe in Indonesia

Not yet recruiting
  • COVID-19
  • BNT162b2
  • (no location specified)
Nov 16, 2022

COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory

Recruiting
  • COVID-19 Infection
  • +4 more
  • COVID-19 Vaccine
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

COVID-19 Trial in Toyoake (EXG-5003, Placebo)

Completed
  • COVID-19
  • EXG-5003
  • Placebo
  • Toyoake, Aichi, Japan
    Fujita Health University Hospital
Jan 24, 2023

Third Dose of COVID-19 Vaccine in Solid Organ Transplant

Completed
  • COVID-19
  • +3 more
  • Three doses of SARS-CoV-2 BNT162b2 vaccine (observational)
  • Two doses of CoronaVac and one dose of BNT162b2 SARS-CoV-2 vaccine (observational)
  • Santiago, Chile
    Pontificia Universidad Católica de Chile
Jan 3, 2022

SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
  • 0.9% sodium chloride solution
  • Islamabad, Pakistan
    Sindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023

COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

Recruiting
  • COVID-19
  • SARS-CoV-2 DNA Vaccine (ICCOV)
  • Wong Chuk Hang, Hong Kong
    Gleneagles Hospital Hong Kong
Jun 16, 2023

Passive Transmission of COVID-19 Antibody From Mother to Infant

Recruiting
  • Passive Transmission of Maternal and Infant Antibodies
  • sars-cov-2 vaccine or infection
  • Chongqing, Chongqing, China
    Children's hospital of chongqing medical university
May 9, 2023

Epileptic Seizure in Epilepsy Patients After SARS-CoV-2

Completed
  • Epileptic Seizures Related to Drugs
  • +2 more
  • inactive SARS-Cov-2 vaccine
  • Xi'an, Shaanxi, China
    Xijing Hospital
Apr 16, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine 10µg, Recombinant SARS-CoV-2 Fusion Protein

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg
  • +2 more
  • Zhuhai, Guangdong, China
    Zhuhai Peoples' Hospital Medical Group
Mar 12, 2022